Skip To Voice Support Menu
For Body
For Menu
For Local Menu
Home
> Investor Relations
Sep 01
Updated Share Ownership Data
Jul 23
Information Meeting on FY 2010.12 2Q Financial Results
Jul 22
Results for Second Quarter of Fiscal Year 2010 (January - June, 2010)
Jul 15
Events & Presentations has been updated with the time of the Financial Results
Apr 23
Results for First Quarter of Fiscal Year 2010 (January - March, 2010)
More
Sep 02
Anti-Cancer Agent, Xeloda
®
Filed for Advanced or Refractory Gastric Cancer By “New Drug Application Based on Evidence in the Public Domain”
[
PDF
163KB]
Sep 01
Renewal of “Cancer Information Guide,” a Website for Patients: - Maximizing Convenience through Unique Built-in Search Engine -
[
PDF
153KB]
Aug 30
Awareness Enhancement of Colon Diseases with Display of Giant-Sized Balloon Art, "Japanese Version of a Giant Colon"
- "Relay for Life Japan 2010" -
[
PDF
255KB]
Aug 06
Organizational Restructuring and Personnel Changes
[
PDF
135KB]
Aug 04
"ACTEMRA
®
" Humanized Anti-Human IL-6 Receptor Monoclonal Antibody Conditions for Approval (All Patients Surveillance) Lifted in Japan
[
PDF
192KB]
More
Mission Statement
Mid-Term Business Plan
Corporate Governance
Directors & Officers
Business Risk
Disclosure Policy
Our Business
History
Articles of Incorporation
Latest Results
Income Statement
Revenue by Product
Balance Sheet
Cash Flow Statement
Performance Indicators
Quarterly Reports
Development Pipeline
Presentation Materials
Annual Reports
Corporate Governance Reports
Downloads
Events & Presentations
Notices
Shareholder Meetings
Share Information
Shareholder Returns
Share Ownership
Analyst Coverage
Bonds & Ratings
Share Price
TSE Code:4519
(About 20 min delay)
Chart
Annual Report 2009
[
5.1MB]
IR Contact
FAQs
Request Printed Materials
What's New
How to Use the IR Site
About RSS
IR Site Map
Disclaimer
Disclosure Policy
Back to top